Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maura Danni

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Journal of Neurology|May 12, 2017
Oral and intravenous steroids for multiple sclerosis relapse: a systematic review and meta-analysisSimona Lattanzi, Claudia Cagnetti, Maura Danni, et al.
Journal of the Neurological Sciences|September 13, 2015
Prediction of disability progression in fingolimod-treated patientsSimona Lattanzi, Maura Danni, Raffaella Cerqua, et al.
Multiple Sclerosis and Related Disorders|July 30, 2020
Long-term outcome in multiple sclerosis patients treated with fingolimodSimona Lattanzi, Chiara Rocchi, Maura Danni, et al.
Multiple Sclerosis and Related Disorders|July 4, 2020
Cerebral hemodynamics in patients with multiple sclerosisSimona Lattanzi, Maria Cristina Acciarri, Maura Danni, et al.
Journal of Neurology|August 24, 2017
Persistence to oral disease-modifying therapies in multiple sclerosis patientsSimona Lattanzi, Maura Danni, Ruja Taffi, et al.
Frontiers in Neurology|January 29, 2015
A RCT Comparing Specific Intensive Cognitive Training to Aspecific Psychological Intervention in RRMS: The SMICT StudyFlavia Mattioli, Chiara Stampatori, Fabio Bellomi, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|August 23, 2023
Effectiveness of Ocrelizumab in Primary Progressive Multiple Sclerosis: a Multicenter, Retrospective, Real-world Study (OPPORTUNITY)Clara G Chisari, Assunta Bianco, Vincenzo Brescia Morra, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Journal of Neurology|May 12, 2017
Oral and intravenous steroids for multiple sclerosis relapse: a systematic review and meta-analysisSimona Lattanzi, Claudia Cagnetti, Maura Danni, et al.
Journal of the Neurological Sciences|September 13, 2015
Prediction of disability progression in fingolimod-treated patientsSimona Lattanzi, Maura Danni, Raffaella Cerqua, et al.
Multiple Sclerosis and Related Disorders|July 30, 2020
Long-term outcome in multiple sclerosis patients treated with fingolimodSimona Lattanzi, Chiara Rocchi, Maura Danni, et al.
Multiple Sclerosis and Related Disorders|July 4, 2020
Cerebral hemodynamics in patients with multiple sclerosisSimona Lattanzi, Maria Cristina Acciarri, Maura Danni, et al.
Journal of Neurology|August 24, 2017
Persistence to oral disease-modifying therapies in multiple sclerosis patientsSimona Lattanzi, Maura Danni, Ruja Taffi, et al.
Frontiers in Neurology|January 29, 2015
A RCT Comparing Specific Intensive Cognitive Training to Aspecific Psychological Intervention in RRMS: The SMICT StudyFlavia Mattioli, Chiara Stampatori, Fabio Bellomi, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|August 23, 2023
Effectiveness of Ocrelizumab in Primary Progressive Multiple Sclerosis: a Multicenter, Retrospective, Real-world Study (OPPORTUNITY)Clara G Chisari, Assunta Bianco, Vincenzo Brescia Morra, et al.
Pageof 1